Patent details

Basic Information

Publication number:

EP2558095

PCT Application Number:

EP2011055906

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP117156919

PCT Publication Number:

WO2011128403

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ORGANIC COMPOUND FOR USE IN THE TREATMENT OF LIVER CANCER

French Title of Invention:

COMPOSÉ ORGANIQUE DESTINÉ À ÊTRE UTILISÉ DANS LE TRAITEMENT DU CANCER DU FOIE

German Title of Invention:

ORGANISCHE VERBINDUNG ZUR BEHANDLUNG VON LEBERKARZINOM

SPC Number:

Dates

Filing date:

14/04/2011

Grant date:

24/10/2018

EP Publication Date:

20/02/2013

PCT Publication Date:

20/10/2011

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

24/10/2018

EP B1 Publication Date:

24/10/2018

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

14/04/2019

Expiration date:

14/04/2031

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

17/10/2018

 

 

Name:

Novartis AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:

SCHMID, Herbert

Address:

Switzerland (CH)

2

Name:

GRAUS-PORTA, Diana

Address:

Switzerland (CH)

3

Name:

SHI, Michael

Address:

United States (US)

Priority

Priority Number:

324936 P

Priority Date:

16/04/2010

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/496; A61P 35/00;

Publication

European Patent Bulletin

Issue number:

201843

Publication date:

24/10/2018

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages